IRCT20170306032913N4招募中2 期
Comparison of response and toxicity of capecitabine and oxaliplatin chemotherapy regimen with taxol and carboplatin with radiotherapy in esophageal cancer patients
适应症
试验速览
- 阶段
- 2 期
- 状态
- 招募中
- 入组人数
- 70
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 40 years 至 80 years（—）
- 性别
- All
入选标准
- •Proper Performance Status.
- •No severe dysphagia
排除标准
- •Age over 80.
- •Cervical Esophageal involvement
研究者
相似试验
尚未招募
不适用
A study of pharmacokinetic analysis of capecitabine and cytidine deaminase activityBreast and colorectal cancerJPRN-UMIN000019244Department of Clinical Oncology and Chemotherapy, Nagoya University Hospital20
进行中（未招募）
不适用
A phase II study of Capecitabine in combination with Cisplatin in advanced head and neck Cancer - NDAdvanced or metastatic head and neck cancerLevel: HLTClassification code 10024530EUCTR2006-003775-13-ITOSPEDALE ONCOLOGICO DI BARI43
进行中（未招募）
不适用
A phase II study of Capecitabine in combination with oral vinorelbine in advanced Breast Cancer - NDEUCTR2006-003752-38-ITOSPEDALE ONCOLOGICO DI BARI
已完成
不适用
Phase I/II Study of Capecitabine in Combination with Peginterferon Alfa-2a for Patients with Advanced Hepatocellular CarcinomaHepatocellular CarcinomaJPRN-UMIN000005697Chiba University Hospital42
进行中（未招募）
1 期
A pharmacokinetic study of capecitabine in patients undergoing peri-operative chemotherapy and a total gastrectomy for adenocarcinoma of the stomach - Capecitabine PK Gastric (CAP002)Patients undergoing peri-operative chemotherapy and a total gastrectomy for adenocarcinoma of the stomachEUCTR2009-009908-39-GBCambridge University Hospitals NHS Foundation Trust13